Cargando…

The present status of radiopharmaceuticals in the country

Detalles Bibliográficos
Autores principales:	Jalilian, Amir Reza, Beiki, Davood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149011/ https://www.ncbi.nlm.nih.gov/pubmed/27980560

Ejemplares similares

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

(99m)tc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation
por: Beiki, Davood, et al.
Publicado: (2013)

Nomenclature for radiopharmaceuticals, consultation of your opinion!
por: Elsinga, Philip H.
Publicado: (2017)

Metal-Based Radiopharmaceuticals in Inorganic Chemistry
por: Boschi, Alessandra, et al.
Publicado: (2023)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy
por: Kopka, Klaus
Publicado: (2014)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration
por: Ayesa, Sally L., et al.
Publicado: (2022)

Preclinical Evaluation of (68)Ga-MAA from Commercial Available (99m)Tc-MAA Kit
por: Shanehsazzadeh, Saeed, et al.
Publicado: (2017)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

Current status and future perspective of radiopharmaceuticals in China
por: Hu, Ji, et al.
Publicado: (2021)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

Direct Technetium radiopharmaceuticals production using a 30MeV Cyclotron
por: Jalilian, AR., et al.
Publicado: (2011)

Greetings from the New President of World Association of Radiopharmaceutical and Molecular Therapy
por: Srivastava, Suresh
Publicado: (2016)

Greetings from the New President of the World Association of Radiopharmaceutical and Molecular Therapy
por: Virgolini, Irene
Publicado: (2018)

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
por: Peñuelas, Iván, et al.
Publicado: (2019)

Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)
por: Jalilian, Amirreza, et al.
Publicado: (2023)

IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)

(68)Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation
por: Hajiramezanali, Maliheh, et al.
Publicado: (2019)

Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
por: Reischl, Gerald
Publicado: (2019)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Radiopharmaceuticals in monitoring cancer
por: Britton, Keith E., et al.
Publicado: (2015)

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
por: Dizdarevic, S, et al.
Publicado: (2019)

Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
por: Kolenc Peitl, Petra, et al.
Publicado: (2019)

Transport processes of radiopharmaceuticals and -modulators
por: Efferth, Thomas, et al.
Publicado: (2011)

Radiopharmaceutical tracers for cardiac imaging
por: Manabe, Osamu, et al.
Publicado: (2017)

Radiopharmaceuticals for Relapsed or Refractory Leukemias
por: Kunos, Charles A., et al.
Publicado: (2019)

Radiopharmaceutical Validation for Clinical Use
por: Kunos, Charles A., et al.
Publicado: (2021)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

The Present Etiological Status
Publicado: (1883)

The Necessity of Checking the Status and Performance of Methadone Maintenance Treatment Centers in Iran
por: Mohebi, Mohammad Davood
Publicado: (2013)

Stroma Targeting Nuclear Imaging and Radiopharmaceuticals
por: Shetty, Dinesh, et al.
Publicado: (2012)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands
por: Martini, Petra, et al.
Publicado: (2018)

Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers
por: Kunos, Charles A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tvo4mf0sl0q6asecahvp4sud49